Shopping Cart
- Remove All
Your shopping cart is currently empty
TDZD-8 (NP 01139) is an inhibitor of GSK-3β, with an IC50 of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $42 | In Stock | |
| 10 mg | $53 | In Stock | |
| 25 mg | $77 | In Stock | |
| 50 mg | $126 | In Stock | |
| 100 mg | $198 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $46 | In Stock |
| Description | TDZD-8 (NP 01139) is an inhibitor of GSK-3β, with an IC50 of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC. |
| Targets&IC50 | GSK-3β:2 μM |
| In vitro | TDZD-8 acts as a noncompetitive inhibitor of ATP or GS-1 binding. TDZD-8 shows no inhibition of PKA, PKC, Cdk-1/cyclin B or CK-II in kinase assays. [1] TDZD-8 specifically induces cell death of primary leukemia specimens. TDZD-8 ablates leukemia progenitor and stem cells. TDZD-8 treatment induces oxidative stress. TDZD-8 induces cell death with extremely rapid cell death kinetics showing loss of membrane integrity. TDZD-8 inhibits PKC and FLT3 in primary AML specimens. [2] |
| Synonyms | NP 01139, GSK-3β Inhibitor I |
| Molecular Weight | 222.26 |
| Formula | C10H10N2O2S |
| Cas No. | 327036-89-5 |
| Smiles | Cn1sc(=O)n(Cc2ccccc2)c1=O |
| Relative Density. | 1.375 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 70 mg/mL (314.95 mM), Sonication is recommended. Ethanol: 44.5 mg/mL (200.22 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.